title: Increased sensitivity to the inhibitory effect of excess iodide on thyroid function in patients with beta-thalassemia major and iron overload and the subsequent development of hypothyroidism.
abstract: OBJECTIVE
  Patients with beta-thalassemia frequently develop primary hypothyroidism and other endocrine disorders due to iron overload. We studied whether administration of excess iodide to patients with apparently normal thyroid function could uncover an underlying thyroid disease.
  
  
  METHODS
  Twenty-five patients, 10 prepubertal (mean age 11+/-3 years) and 15 adults (mean age 23+/-5 years) with normal thyroid hormone and TSH levels, a normal response of TSH to TRH and negative thyroid peroxidase antibodies received 20mg iodide three times daily for three weeks, and thyroid hormone and TSH levels were measured weekly during, and for three weeks after, iodide administration and every 3 months thereafter for the next 5 years.
  
  
  RESULTS
  During iodide administration there was a significant decrease in thyroid hormone concentrations which remained within normal levels, and a significant increase in TSH concentrations which in 14 out of 25 (56%) patients reached the hypothyroid level. Baseline TSH values were higher in those patients who developed subclinical hypothyroidism (2.31+/-0.71mU/l vs 1. 34+/-0.64mU/l, P=0.0016). Subclinical hypothyroidism developed in 70% of prepubertal and in 47% of adult patients. Serum ferritin was elevated in all patients. Nine of the fourteen patients (64.3%) who developed subclinical hypothyroidism during iodide administration developed hypothyroidism during the 5-year follow-up compared with only one of the eleven patients with a normal response to iodide (P=0.004).
  
  
  CONCLUSIONS
  Patients with beta-thalassemia should not be exposed to excess iodide due to increased sensitivity to its inhibitory effects on thyroid function. The susceptible individuals frequently develop permanent hypothyroidism in the following years.
authors.affiliation: Endocrine Division, Department of Medicine, University of Patras Medical School, Patras, Greece.
authors.forename: T
authors.initials: T
authors.lastname: Alexandrides
authors.forename: N
authors.initials: N
authors.lastname: Georgopoulos
authors.forename: S
authors.initials: S
authors.lastname: Yarmenitis
authors.forename: A G
authors.initials: AG
authors.lastname: Vagenakis
mesh_terms: D000293:Adolescent; D000328:Adult; D002648:Child; D002675:Child, Preschool; D005260:Female; D005293:Ferritins / Q000097:blood; D005500:Follow-Up Studies; D006801:Humans; D007037:Hypothyroidism / Q000000981:diagnostic imaging / Q000209:etiology*; D007454:Iodides / Q000009:adverse effects / Q000494:pharmacology*; D019190:Iron Overload / Q000150:complications / Q000000981:diagnostic imaging / Q000503:physiopathology*; D008111:Liver Function Tests; D008297:Male; D013960:Thyroid Function Tests; D013961:Thyroid Gland / Q000000981:diagnostic imaging / Q000503:physiopathology*; D013963:Thyroid Hormones / Q000097:blood; D013972:Thyrotropin / Q000097:blood; D014463:Ultrasonography; D017086:beta-Thalassemia / Q000150:complications / Q000000981:diagnostic imaging / Q000503:physiopathology*
chemical_list: D007454:Iodides; D013963:Thyroid Hormones; D013972:Thyrotropin; D005293:Ferritins